![]() They laid off a great number of staff members and cut funding to the research projects such as hair cloning. This was not solely the result of the failed tests, as the company's financial background also became unstable in 2008 and they had to implement several cost-cutting measures. In 2008 Intercytex admitted that they failed in fully developing the hair cloning therapy and decided to discontinue all research. However, these tests did not show the expected progress. They estimated they would be able to finish the process in a few years. The company was hoping to complete the research so they can make it available to the public, so they began Phase III trials. They tested the method in their Phase II trials, which showed very promising results as two-thirds of the bald male patients were able to grow new hair after the treatment. They hoped that if they multiplied (cloned) the follicles and then implanted them back in the scalp in the bald areas they would be successful in regrowing the hair itself. Intercytex tried to clone new hair follicles from the stem cells harvested from the back of the neck. ![]() This therapy would also eliminate the need for donor hair, as it can be simply grown from the patient's own cells. ![]() Researchers at the company were convinced that their approach was the cure for baldness, and if the technology is fully developed, they can basically eliminate hair loss due to hereditary factors. One of the first companies to begin experimenting with hair cloning was Intercytex. There are already effective/semi-effective treatments for hair loss such as Finasteride, Rogaine, and hair transplants, but follicle cloning will be a "holy grail" in which new hair follicles can be cloned and implanted at will. This technique however is still in the research phase and is not available for public or commercial use.Īs of 2023, estimates for when there will be successful hair cloning for humans are around 2030-2035 recent advancements in stem cell research and follicle generation mean that balding may be solved in around 10 years. Scientists believe they may have solved this problem by using nearly microscopic 3D-printed shafts to assist follicles growing upward through the scalp. In 2015, initial trials for human hair were successful in generating new follicles, but the hairs grew in various different directions, giving an unnatural look. They can be multiplied (cloned) by various culturing methods and the new cells can be injected back into the bald scalp, where they would produce healthy hair. The basic idea of hair cloning is that healthy follicle cells or dermal papillae can be extracted from the subject from areas that are not bald and are not suffering hair loss. One recently discovered molecule (SCUBE3), may aid in activating these cells and regrowing hair. The abnormal behavior of these follicles is suggested to be the result of progenitor cell deficiency in these areas. However, it was discovered that the follicles are not entirely absent, as there are stem cells in the bald scalp from which the follicles naturally arise. Scientists previously assumed that in the case of complete baldness, follicles are completely absent from the scalp, so they cannot be regenerated. The technology to clone hair is in its early stages, but in October 2022, scientists from Yokohama National University successfully cloned fully mature hair follicles in mice. Hair multiplication or hair cloning is a proposed technique to counter hair loss. ( February 2014) ( Learn how and when to remove this template message) See Wikipedia's guide to writing better articles for suggestions. ![]() This article's tone or style may not reflect the encyclopedic tone used on Wikipedia.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |